As mentioned above, the accumulation of ADO contributes to tumor progression, which could be linked to T cell effector function impairment, and ADORAs could modulate human peripheral and tumor-infiltrating lymphocyte (TIL) function. The gene discussed is ADO; the disease is neoplasm.